Google TrendCHAMPIONS LEAGUE SCHEDULE (500+) — Champions League Matchday 2: Key stats and what to look out for in every game
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "How Do Updated NCCN Guide" (30 stories)

Top Headline Story

How Do Updated NCCN Guidelines and ctDNA Data Reshape MIBC Treatment?
Lead StoryCancerNetworkgeneral
Jul 17

How Do Updated NCCN Guidelines and ctDNA Data Reshape MIBC Treatment?

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOVEZaNmRKT0hoSVVvVzZpVWNxeWUyZlpCY0MwR0RObkNkV3ZNZmRraWhMdWhzdU9ub2huNVlRdEpzVkM5VE0zOVNzUEZrLTR2YXp3YndDemtVZEY0VmltaFdybmFGQWJpRzg3Z1dUZVVYblo1YXBfWWplLXlQdklfbmhKc2d6MEgxaWV1M0NSRVIzOVIwZmVTbUdPQkxnbUtNa1gwLWJORQ?oc=5" target="_blank">How Do Updated NCCN Guidelines and ctDNA Data Reshape MIBC Treatment?</a>  <font color="#6f6f6f">CancerNetwork</font>

Real-time search volume
500+19m ago

champions league schedule

Champions League Matchday 2: Key stats and what to look out for in every game

500+29m ago

matthew stone sr

Victims of Pennsylvania mass shooting included pregnant daughter of gunman

500+29m ago

geomagnetic storm aurora visibility northern us

Northern Lights Forecast: Aurora Could Be Visible From These 10 States Monday

5000+49m ago

selma blair

Selma Blair Arrested, Attacks Flight Crew After Trying to Open Plane Door Mid-Air

Search Results for "How Do Updated NCCN Guide"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Updated NCCN Guidelines Recommend Rusfertide Across Polycythemia Vera
OncLivegeneral

Updated NCCN Guidelines Recommend Rusfertide Across Polycythemia Vera

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNc0tUQm1YSm9GanQ5N2FsNXpYMENfT2RXdVgwNW5OUmc2VllZalRqbVgxV2wzZktjZlprU01IQm1FS0tCSHY1VHJIUlFkRXB5R3piaE42aVlhM2hPZVN5Y0lXczRhQVcwNEVjcFRDWkVaNm13UTdxeUhZR0I0eTBZSVNNS21oV1ZZNERlak5mS1JMdWpSX1RhdFQwTmpYdms4ek95V2d6a3E?oc=5" target="_blank">Updated NCCN Guidelines Recommend Rusfertide Across Polycythemia Vera</a>  <font color="#6f6f6f">OncLive</font>

New NCCN Guidelines Bring Standardized Care to Children With Ewing Sarcoma
Bioengineer.orggeneral

New NCCN Guidelines Bring Standardized Care to Children With Ewing Sarcoma

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQaUp5MEljTjctZUhTSmJ3cFI4MEdpTmUwam9vLVE2aWNZT1gtT19hQkJFUjFmc3FZQlNHVkZsMVRRM0NNSWVDQmJjajVwaW9uUmZ6NUxETTNwenU4UGgzaDNWSXg0a0t1MDVGdzEyYmVKTW8tUi1qeDlhZVVFQVRuUWxBaHJva3BMb19LT0pUeHdNYTJ1LTA1NDBNOVU2WlRx?oc=5" target="_blank">New NCCN Guidelines Bring Standardized Care to Children With Ewing Sarcoma</a>  <font color="#6f6f6f">Bioengineer.org</font>

What Ophthalmologists Should Know About the 2026 NCCN Uveal Melanoma Guidelines
Cleveland Clinicgeneral

What Ophthalmologists Should Know About the 2026 NCCN Uveal Melanoma Guidelines

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE14UUZuMW5lM3hDSDBjMXJrTnBQMFAydEk5cElOMURyM2tsNVF5WjhEbDI4dEswRTJrN0dRN3hUOTZiZE5TZ09GWFBEN1JlNF9GeE92aEp2WTJOcXlPeU5ZSUhneU1WeF9hUlB2bVBidlZlLWllSGc?oc=5" target="_blank">What Ophthalmologists Should Know About the 2026 NCCN Uveal Melanoma Guidelines</a>  <font color="#6f6f6f">Cleveland Clinic</font>

2026 NCCN Clinical Practice Guidelines in Oncology®: Key Updates Across Tumor Types
The ASCO Postgeneral

2026 NCCN Clinical Practice Guidelines in Oncology®: Key Updates Across Tumor Types

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQbmM5WklLVlo0S2Z1MHByUmIwVWRQaEZNblNOak1PU0lTUWoycHkweWJsUURrSkhGY005M2szRE9vMEpRbVhoVUNSdG9ydEY0ZXlBN2d5cU1jbk12M1cxdE1GLXQtQ3VtRHJnX2VKNHBITUx0RDd2al9MckRFWEhxajh5ZEZMVXpYamQtN3FpMG9yeG54ckFSTjJ6LVhhTU5yVWZYYk5vNHJTMEJnZ1VsMlRObmJwVG9HOXo5VXFCdw?oc=5" target="_blank">2026 NCCN Clinical Practice Guidelines in Oncology®: Key Updates Across Tumor Types</a>  <font color="#6f6f6f">The ASCO Post</font>

NCCN Guidelines Expand First-Line Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer
Pharmacy Timesgeneral

NCCN Guidelines Expand First-Line Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxPTmF4UjBLTS1GRllGWGpobEw0a2tWVHJPZXk2eEV5T3RMb18wUEd6bDQ0QUlRcmEtNjJucXhMdXlOLXN5YnlKNGdkWGwzcU5OanI2R3E3MHVuS05oVk1kWl84WkhVazJKbmJCb2llQlBPbmU3ektZWGQ3a053bmJ5ZHZKQ2x2N3Vldm5EQ3pacEpaaWJ5cjJjVzNVZGp3WWdCd29pS3R0SzZicDdKTGdzdy1rQlBBQjZZS1VEX0FKaE1JVlBWVEZXUERjb3gxRktj?oc=5" target="_blank">NCCN Guidelines Expand First-Line Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer</a>  <font color="#6f6f6f">Pharmacy Times</font>

Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®
GlobeNewswiretech

Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®

<a href="https://news.google.com/rss/articles/CBMi0wJBVV95cUxOOWJpd2RiUFVDbzFzbkxlYmlpbWlMNUtsMEp1R1psaDhlRGZaU2g5bnNPOUZ1UlV0U0RmcVZtLTJULXhEU1FQYkFKcTZmYnctaFFhdl9FeU03YldfYjFiOXRxa0FMU0tuU0padmJ6NktETXk4NnNNdjZmNHZKU24ycDVrbzllM005SUdMV1ktZ1VpNE9JdkhjSjk3ZnpZa0Z0dHZUSWd4Qlcxb3FlQktxYkY4TkpLZXpRUWx1NHdGRjNIUjNBUUpVd05TcG9kYlliQ1ZaM29XQ3NPcF9aZXRycXpaZ25uSEZCVHZyUlB0NFJuYU1SMXFWenVXaHQ3d1JRTF9oQVV6LXIxMU5ITzRqWElTS1dONDZaQTh6eTVsYjIwRXNhcElhZzBUREVETEVKZ21tUTFVUXFVeFdGVWt0aDdHM25jNlV1anV5NW50ZWlrMlE?oc=5" target="_blank">Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®</a>  <font color="#6f6f6f">GlobeNewswire</font>

From Guidelines to Community Practice: Translating the Latest NCCN RRFL Updates Into Action
AJMCworld

From Guidelines to Community Practice: Translating the Latest NCCN RRFL Updates Into Action

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNWkZqVHBUZjJ6UUk4UU1qRWlnSFdJYmF3V2dQYVhoZy1XYnlGY2FWOFk2N3E3R0xVUUdPT0I2V0pTbTBPQ2ptS2hrWHVrcXFGNW9STFB1dkZuNm9UUV80M0hSdzZrVnVQb2pFWGZNT1dNNlRNdHd2RmUzdW9IV0R1VXI0NGNOMkdENlZ3Y3JUZFM2QU1NYm1mUkd4ZXhmdlNteFJ4ZUF0MDg3VlI1MUxRWGFXUmhQTWM?oc=5" target="_blank">From Guidelines to Community Practice: Translating the Latest NCCN RRFL Updates Into Action</a>  <font color="#6f6f6f">AJMC</font>

New cancer guidelines favor a test that finds 1 cancer cell in 1 million
Stock Titangeneral

New cancer guidelines favor a test that finds 1 cancer cell in 1 million

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOU1IxdmdFUWh1aUdBZDhYQ2pmTnhnZ2ZTZ1BiOGJ4c0V1UFNxLXQ2SEVCT3ZZbGtpWFREZzdSQzFEWjlUTEVfTDczS2ZEbXdfak80U0FsT2w5d01nWHRWX3Ewa0ltaUZkSGtvZG5zRXZEaWtad2NGUENycUlqOXJfTGV2UW5xd0JPRmlObmQ0aGc4elBDUXJtcGVpQXZwMVJBdXVXMENFbng2cUNYMXlQNGdwYVBvYUtzRTdB?oc=5" target="_blank">New cancer guidelines favor a test that finds 1 cancer cell in 1 million</a>  <font color="#6f6f6f">Stock Titan</font>

New NCCN Guidelines Call for AI-Based Mammogram Risk Assessment at 35
Breast Cancer Research Foundationtech

New NCCN Guidelines Call for AI-Based Mammogram Risk Assessment at 35

<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxOV1FHVzg3Q3lFMWJNQlZINXkzWmVUemFXSGJsckpYeUtOeUpkNEt1NTI1M0xLUU1KbVpQQUJTRFd4VGxLczdkM0h2NlQxaENpOWFNVkFqVk5CYjFhMTdObzNEWmlpQUxMT3g1MC1fRnNZZzBoQ2ZJN3NSVzRTelVTOVpsTHVRNXJxX1VMcklpMmtrY0xLSEM2M3JJWWV0WF93RXRfNlVyXzdUMGNHenk3UDd4RjlZQWdoajBDYVBmMTY1dkhpalB2b3JRd2wtZ2c?oc=5" target="_blank">New NCCN Guidelines Call for AI-Based Mammogram Risk Assessment at 35</a>  <font color="#6f6f6f">Breast Cancer Research Foundation</font>

NCCN Updates Breast Cancer Guidelines to Include AI-Based Risk Assessment
Targeted Oncologytech

NCCN Updates Breast Cancer Guidelines to Include AI-Based Risk Assessment

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOUlNKUmJtTmxpZnNIV1JLLW51UkZLWXFrd3BnLWZGNHl6QkpRcGI1OUs2SnJCU3lPUnVYTkZLOXVoYTN3TFVXYlctdWFvT3pUWl9Xd0ppM1kwYjM3dW83VnhweGdYYndXYUZmTWRtUFROeVdldV9RRVBvNTRUazl1QXZuVVNMU3lVdllzcTR5QXBKNHJWVll1bG4xMzFUVTJpaWtFWmdoNzUwZw?oc=5" target="_blank">NCCN Updates Breast Cancer Guidelines to Include AI-Based Risk Assessment</a>  <font color="#6f6f6f">Targeted Oncology</font>

NCCN launches a free service for updates on clinical cancer guidelines
News-Medicalworld

NCCN launches a free service for updates on clinical cancer guidelines

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPT3REdE5jV1EyVnI3WXc2LWFKRldXWGdQSm42Q21pbkp5OTFBcUN6dUdlSkNCMHVCOWJYQklHTWx3SmpzVFdtYVJTZHNvdlFsRnljZmlOODRnWEtYS2xxT0pqNXRxWW9ZZFg4MHZ5aGJqdXVqNmlnOURPdTNkX0pSZzZCTDRhTGFFbWVXRW1iQjZJUTVpZUhLZGhBSmVoZTJ0WjM4MGdzSzJZU0RlU3h2MS1QTjUyVmswMVE?oc=5" target="_blank">NCCN launches a free service for updates on clinical cancer guidelines</a>  <font color="#6f6f6f">News-Medical</font>

NCCN recommends ctDNA-MRD testing to guide adjuvant treatment post-cystectomy
Urology Timesgeneral

NCCN recommends ctDNA-MRD testing to guide adjuvant treatment post-cystectomy

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOYm9DWTF2bmtxd3hHZ2NDbGk4NmJmTklaRk9rMFM1TDNUdEN4dmVBZllqX0ZrZGprZGp4RFNuaENJbTE1WUV2MGRvX0g2b3pDeDU5eU8zZkpySHg3ZmVrOU5lcE5rUFN6Qk1tM1cxZFo1UDVsTVJqQmJ4WTd2VUlqU0J4MnZlS0FLZmFJOUhnQk5hbTByejJYM2tfUjhuazNzVGItV3RJSFN1YXRJczUzcw?oc=5" target="_blank">NCCN recommends ctDNA-MRD testing to guide adjuvant treatment post-cystectomy</a>  <font color="#6f6f6f">Urology Times</font>

NCCN Releases Updated Guidelines for the Treatment of Breast Cancer
Cancer Therapy Advisorgeneral

NCCN Releases Updated Guidelines for the Treatment of Breast Cancer

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOMlA3WGVmT0otR0k4eDlNaWlqeVhwRDVTaUxrTDk5SC1LYWFPd2lvUHNkQ3FSNmFZb1R5T0VMYlZRQmp3S1RhaXNXM1BHcDZ5MXB3MGYyeHh0VmM0TjI4d0pGT2txSDRGSmZ1QklLMjRFZTU5ZEVLUUpCYmNYVW1kbUxKbmFTQTA3V1dyeDNNMS0zc2p3cUpmOWp1RXRlSmVI?oc=5" target="_blank">NCCN Releases Updated Guidelines for the Treatment of Breast Cancer</a>  <font color="#6f6f6f">Cancer Therapy Advisor</font>

Updated NCCN Guidelines Feature Additional MRD Recommendations in Multiple Myeloma
OncLivegeneral

Updated NCCN Guidelines Feature Additional MRD Recommendations in Multiple Myeloma

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQRHN2c212RnlNanZfRVc0VkEzU0hTaTgtXzh5SGpSaXJVTUN1YzVTSmpCMnprSVNaT2VHSXRET0QtLUh3dTBja0k3bHY4YnV6ZkVtcE5pUWFlZ0NrS2FRU2pUcXVPOXBFc1I0c2c3a3N2NWtqZ3BsaXFMdS0teV92SklvOW1FbTdiRUdCRFlnaEJVQk5NT3Vha3M0OFo5Y3BHdFRNVF9pZk9DcVhOUmZFNA?oc=5" target="_blank">Updated NCCN Guidelines Feature Additional MRD Recommendations in Multiple Myeloma</a>  <font color="#6f6f6f">OncLive</font>

NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing
CancerNetworkgeneral

NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxOT0ZwRHVjdVhEWHBzNTFZTFVtTjRfV2tkRk1KZ1BZajctOUl4M1BZWWp3RV8zQU51VW9YSDVDWE9WYnUxR3FIOHA1UEFxWnYxRFEtdGZVOS1FM0FEZDk0ZUR5X1FpbXJzQVRrUmhVQWU0bkpFREVYYjJSa0gwTG16aDd3ek5QUUJwcEpNTkxWdXlwMThQZ2JNaTFQQQ?oc=5" target="_blank">NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing</a>  <font color="#6f6f6f">CancerNetwork</font>

NCCN Guidelines in Focus: Key Updates for Follicular Lymphoma and Their Impact on Formulary Decisions
The American Journal of Managed Caregeneral

NCCN Guidelines in Focus: Key Updates for Follicular Lymphoma and Their Impact on Formulary Decisions

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxNazJ5a1RtQlltVU1scVpJZDFGNVVTb1lfLXU0WmxIS0dvTUY3S01OTW8tV19XdS1LMGFsMmtmdnl5M1ptbko3TXBmMVZVbkpHV2IxaHE1bEZSU0NUanBVWHcxNWZ3YWRsZF9YdTlwRjJCYkRIZVBSaEtJbHVwU05iMEdBTzhkeEU1WkVJVjNfVWtzMmJXSVU0QndXMnlUOXlJRnlNbEczZkIxWkZaT0JzZnVUa2IyNl9nWlFFaUVJd19uQ0c3?oc=5" target="_blank">NCCN Guidelines in Focus: Key Updates for Follicular Lymphoma and Their Impact on Formulary Decisions</a>  <font color="#6f6f6f">The American Journal of Managed Care</font>

NCCN Expands CSF Molecular Profiling Recommendation to Inoperable High-Grade Glioma
CancerNetworkgeneral

NCCN Expands CSF Molecular Profiling Recommendation to Inoperable High-Grade Glioma

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOZ1F0ZUFlVUFURXdmYUtxb2RTZklTRmxRa2wzQmZCUUtTRUpweDBUSkhyTmpHVnBfWWswaVVSYV9KdFhnTVJUdDVtU0ZRbzZhZFN2RmFRRmpRem5YeFpuX3Y5LVREbEw5N3BUZ2t5OGNUVkJyWDVLYm40dVhSME9FMzlfeDg0UzBDd1FtcW1uTFVYRUlSUVd4SnlzMDJ6S2R3TGY1WFVZVkxGZHhPb1N4cGpCM3A1TjlxR2c?oc=5" target="_blank">NCCN Expands CSF Molecular Profiling Recommendation to Inoperable High-Grade Glioma</a>  <font color="#6f6f6f">CancerNetwork</font>

Navigating ctDNA-Guided Decision-Making in Muscle-Invasive Bladder Cancer
CancerNetworkgeneral

Navigating ctDNA-Guided Decision-Making in Muscle-Invasive Bladder Cancer

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOSG1qVnplaUJYNkZhTl94MVJoMUFlRk5qUjNOR05FX1c4MHNOdV9DdktuY0tDZ01VdWpXcVBpMHY5VGR0VkhmTjJWVVVpRG50ZFAzQjJrQ2FWNVQyM203Z1VIZTktbTdTMDd6LWxhU0NSenBZLVhtYWhTVHdfdEF0MzhlbUgzUURUZGFobm5FQ1ZxOVVkYkQwZkhlajFVZDFGdjMtYUE3cVMxRnY2?oc=5" target="_blank">Navigating ctDNA-Guided Decision-Making in Muscle-Invasive Bladder Cancer</a>  <font color="#6f6f6f">CancerNetwork</font>

NCCN Guidelines: Navigating ctDNA MRD Testing in Evolving MIBC Paradigms
CancerNetworkgeneral

NCCN Guidelines: Navigating ctDNA MRD Testing in Evolving MIBC Paradigms

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPTEJLbXlLY3dhNVRxTUZYcUJNb0NfekdaRUQwX2JDcGYwOHF5YjRBb09hS1kwdmJDYXFKWlpwY0pFNUhYaFNrTUZ1YmVjUVlGa25heHdOaFd6MEYxSFg0bWtUTWc0S2pVeG5tUXY4Wnk4N0Y2ZzdJYldmTDZaU1VZei0za2RMWVBHNEJ1U1haV3F3aXNwbEZ1UHNhYzdXSkQyS3FqTzQ0NEQ5Zw?oc=5" target="_blank">NCCN Guidelines: Navigating ctDNA MRD Testing in Evolving MIBC Paradigms</a>  <font color="#6f6f6f">CancerNetwork</font>

Does Physician Education on New NCCN Guidelines Change Behavior? Data From Ontada Say, “Yes”
AJMCgeneral

Does Physician Education on New NCCN Guidelines Change Behavior? Data From Ontada Say, “Yes”

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQWHpiTTRhTU5OYUdReWJrT0dBUWxmdmw1ZjZJSUNEU29BamRnVjhGbmRZTDctdk9jWDkzNDY1NlkxOG5PRHBWWWc0TV9XSlFRbXc2X2M5OXBuRnlTTUR4eW8yWDZlVnFmcENsTzhqZ3hUcFBLY3dtcDk4ZENUSUo0RjRvQl9FY3FWZXJWMjh5S1ZScXM1bmlQMkZNaDFRMnF5RXVGUDlOWmc4cWRYUzZJT2ZZRkxuUQ?oc=5" target="_blank">Does Physician Education on New NCCN Guidelines Change Behavior? Data From Ontada Say, “Yes”</a>  <font color="#6f6f6f">AJMC</font>

NCCN Guidelines Recommend ctDNA-MRD Testing in MIBC Care
Targeted Oncologygeneral

NCCN Guidelines Recommend ctDNA-MRD Testing in MIBC Care

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQaWtqYVJOVGVzcFAxUzBQTk9xTE5zeFlvMm56UTBDcExCVUtFRUN0Z2N6dkt1TjByamI2TkcwLXFobGdmRE4ta2FwUWFsNFVSZDRjV1N1RmZoV05rTzFiZVltRnRlWnphQU1RU2RLRUkyQnVKdXpDaFRQVm96MS0wX3BWRHp6QzF0NkNGeG1ETHlxXzQ?oc=5" target="_blank">NCCN Guidelines Recommend ctDNA-MRD Testing in MIBC Care</a>  <font color="#6f6f6f">Targeted Oncology</font>

NCCN publishes new patient guide for prostate cancer screening
News-Medicalgeneral

NCCN publishes new patient guide for prostate cancer screening

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxOQjE1d0Y2NUlRSGxDbnJ3WTJmenR5Y0U5eTN2eldkbFhYd09idDlpVjRUcmplSDhCc21uZTBNaG43cnJUNkZYbl83cWhoNkxETGdOX09TRDZKNUxkaC00cTFaNlpFZVRfd0hmYVZHcExjclJ3U3pudTNxel9aaV9NOXVNTEFrY2dEZ09iUk84U1YzQXotZUx2RUtFTy1QUTJQeEljUnhpQUF0SHhmUkxV?oc=5" target="_blank">NCCN publishes new patient guide for prostate cancer screening</a>  <font color="#6f6f6f">News-Medical</font>

ctDNA MRD Guidance in Bladder Cancer: Pharmacy Specialist on NCCN Updates
CancerNetworkgeneral

ctDNA MRD Guidance in Bladder Cancer: Pharmacy Specialist on NCCN Updates

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQLU1pWGM4NnNndGJqQmZDcDVLMmxqWXRoOWtsSHRvTmJiUXhiV2dlTHVEUnl2NzVOZTcwUlI5RS1qb0xlclQycjJPUHJCTXRXOUZxNndJRFNUNVk1NG5qSTFXUWVzeVJJSUFqcU14RHRIMk8tZVB3VlVrUE5HcndNY3A4T1VQSnlmaGs0dG1YNTh5T2gzaU9EU0QwdmZjN28?oc=5" target="_blank">ctDNA MRD Guidance in Bladder Cancer: Pharmacy Specialist on NCCN Updates</a>  <font color="#6f6f6f">CancerNetwork</font>

Clairity Breast Is Added to NCCN Guidelines for Breast Cancer Screening and Diagnosis
OncLivetech

Clairity Breast Is Added to NCCN Guidelines for Breast Cancer Screening and Diagnosis

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOSGdqN3VBTkhpNFI5TWV6c2I2Ti1nb2tnSUZaSFNHYXdmZkhDSkl0b2lHTVZWSXctWTVNVUVkZV9nMUo5bWZZdjRJN3JzQXhCZ3laOTdZTmdIYXBpWVJIRURrQlFIdExuQU5mdkloU05nel9SRXRyQkhFWlotbGhQd29acVpfa3NhUFBlRkpjcGpEM1JrYjhUVnlNWUd5SnVZczJfeDd4M2JNVUxUNkw3X2YzM28?oc=5" target="_blank">Clairity Breast Is Added to NCCN Guidelines for Breast Cancer Screening and Diagnosis</a>  <font color="#6f6f6f">OncLive</font>

Experts Unpack the Most Notable NCCN Guideline Changes Heading Into 2026
OncLiveworld

Experts Unpack the Most Notable NCCN Guideline Changes Heading Into 2026

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQcXJHRW5qTXJBZVR1ZVNPdXk5NFI1SjJHdGRhQVBfdkVyOFd5MHZDSFhRajZzWEJYLUhzaUpEdUtac0VYUnk0SnpPMTBSMjlzZFZjRFZ0cFpiUjItN0tsaV9pZm9UZV9xRnpaSU93bG1HUlowT0lXR01kQWFkS0ZseHV0MFpzVlp5WUN4aFg3b0dmS3FYWnZwYXUwck1tTzlwZnlj?oc=5" target="_blank">Experts Unpack the Most Notable NCCN Guideline Changes Heading Into 2026</a>  <font color="#6f6f6f">OncLive</font>

Updated NCCN Guidelines Recommend First-Line Sacituzumab Govitecan–Based Regimens for TNBC
OncLivegeneral

Updated NCCN Guidelines Recommend First-Line Sacituzumab Govitecan–Based Regimens for TNBC

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQaUlSTHU2cXdIZHdrajN5ajY2ODU5dEttV0pURFYtTzFqWklYRG9jcTU2OVFKX3k3UUs5cko0c2V0UkN2N1BPM19pU3JxZFdhWHB0bTMwOU41OEttY0VkYTRhOWU0RmRMeUVndGhRM0RCRjZzXzRONlgtNXEtV0REMHBuWERZVDdpWGhiXzBXU0ZmZW5OX3RsbnpoYnhNSGVJV3hiWDZEaTZQd3ZOMXBXclhGa1RvYk1PZ1FR?oc=5" target="_blank">Updated NCCN Guidelines Recommend First-Line Sacituzumab Govitecan–Based Regimens for TNBC</a>  <font color="#6f6f6f">OncLive</font>

NCCN Updates Breast Cancer Guidelines: Sacituzumab Govitecan for 1L TNBC
Targeted Oncologygeneral

NCCN Updates Breast Cancer Guidelines: Sacituzumab Govitecan for 1L TNBC

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOMXB1aFpqWlFVMTNzb00xRlZuYmJLcERRQy1PdTF2SmdDeVVkVjNQVnV0RW1RVUJUMFV6SVJPNkhCRDNhQ3lyVjRhVFRBVHY0LXFJb0l3d19GRG1SLXpTSUpqVTd3a1R0OWJuclVCZjhQVEFYRGZhNzl5WTBlRGliZXRxd2ZPX01vbmxMc19SYm5XeWloV2ZBbWZFMy1leWhQTk5KWDVwTQ?oc=5" target="_blank">NCCN Updates Breast Cancer Guidelines: Sacituzumab Govitecan for 1L TNBC</a>  <font color="#6f6f6f">Targeted Oncology</font>

NCCN Guidelines Add Novel Therapeutics to First-Line TNBC Armamentarium
CancerNetworkgeneral

NCCN Guidelines Add Novel Therapeutics to First-Line TNBC Armamentarium

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPS01NUEY4ekprb01xOHVJNXJrbkFCZWEzalBHcG9ZQXplcllHc1hnSElyM1hJc2dqUVpzWTFxV2hhMXV5Z2lpcnBab1Vic2NNcnI3aTJSUFBTVmMwMXhNdm5iNE1YREktWjBhdTA0al9NZ1F0UXZyQnlCeks0U2FPeE1CR0NzZ0dyaG1EX0JOSUxOd2VHVUlnRHpqbmVjRGQtQWZlaEk2Y0FRZw?oc=5" target="_blank">NCCN Guidelines Add Novel Therapeutics to First-Line TNBC Armamentarium</a>  <font color="#6f6f6f">CancerNetwork</font>

Managing Cancer-Related Distress: Overview and Updates of the NCCN Guidelines
Gastroenterology Advisorgeneral

Managing Cancer-Related Distress: Overview and Updates of the NCCN Guidelines

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQdm1CSVBVZWQwMXVtaWVRVW8zdVdjbXBIMjZsc19odUhHa0NPSnhkcEdORGlNTTlUZGVSRWtrUEJzeVoySGR2UVVfM25naktqVVNYZUIxTXh2cjJmSmxEcERzTF9yT0JCYW91Vmx6TEdNNWM1Nlp6QndQd2VnNXRNQm8xVlp3dnJLaUFxWHdZWmF1VEk?oc=5" target="_blank">Managing Cancer-Related Distress: Overview and Updates of the NCCN Guidelines</a>  <font color="#6f6f6f">Gastroenterology Advisor</font>

"How Do Updated NCCN Guide" — Live Google News Trends & Headlines